These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31734054)

  • 21. [Expressions of endothelin-1 in benign prostatic hyperplasia and prostate cancer and their significance].
    Zhou WQ; Sun YH; Yin HL; Zhang ZY; Ge JP; Cheng W; Ma HQ; Wei W; Zhou SG; Ma HH; Gao JP
    Zhonghua Nan Ke Xue; 2007 Aug; 13(8):685-9. PubMed ID: 17918704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin C supplementation prevents testosterone-induced hyperplasia of rat prostate by down-regulating HIF-1alpha.
    Li SH; Ryu JH; Park SE; Cho YS; Park JW; Lee WJ; Chun YS
    J Nutr Biochem; 2010 Sep; 21(9):801-8. PubMed ID: 19716283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical expression of interleukin-2 receptor and interleukin-6 in patients with prostate cancer and benign prostatic hyperplasia: association with asymptomatic inflammatory prostatitis NIH category IV.
    Engelhardt PF; Seklehner S; Brustmann H; Lusuardi L; Riedl CR
    Scand J Urol; 2015 Apr; 49(2):120-6. PubMed ID: 25363611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative analysis of biological profiles of benign prostate hyperplasia and prostate cancer as potential diagnostic, prognostic and predictive indicators.
    Makarewicz R; Zyromska A; Andrusewicz H
    Folia Histochem Cytobiol; 2011; 49(3):452-7. PubMed ID: 22038225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate-specific antigen, androgen, progesterone and oestrogen receptors in Benign prostatic hyperplasia: human tissues and animal model study.
    Wang H; Liu C; Dong Z; Chen X; Zhang P
    Aging Male; 2024 Dec; 27(1):2391380. PubMed ID: 39140708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association between local atherosclerosis of the prostatic artery and benign prostatic enlargement in humans: Putative mechanism of chronic ischemia for prostatic enlargement.
    Haga N; Akaihata H; Hata J; Aikawa K; Yanagida T; Matsuoka K; Koguchi T; Hoshi S; Ogawa S; Kataoka M; Sato Y; Ishibashi K; Suzuki O; Hashimoto Y; Kojima Y
    Prostate; 2018 Sep; 78(13):1001-1012. PubMed ID: 29786870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progesterone receptor in the prostate: A potential suppressor for benign prostatic hyperplasia and prostate cancer.
    Chen R; Yu Y; Dong X
    J Steroid Biochem Mol Biol; 2017 Feb; 166():91-96. PubMed ID: 27125450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia activates the hypoxia-inducible factor-1α/vascular endothelial growth factor pathway in a prostatic stromal cell line: A mechanism for the pathogenesis of benign prostatic hyperplasia.
    Zhang T; Mao C; Chang Y; Lyu J; Zhao D; Ding S
    Curr Urol; 2024 Sep; 18(3):185-193. PubMed ID: 39219634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Histological characteristics of the prostate in men who receive re-TURP for benign prostatic hyperplasia and their clinical significance].
    Sun QZ; Guan TY; Qi JG; Cao JY; Wu G; Yang N; Cheng ZY; Liang J; Wang Q
    Zhonghua Nan Ke Xue; 2010 Feb; 16(2):118-22. PubMed ID: 20369693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoxia-inducible factors HIF-1alpha and HIF-2alpha expression in bladder cancer and their associations with other angiogenesis-related proteins.
    Ioachim E; Michael M; Salmas M; Michael MM; Stavropoulos NE; Malamou-Mitsi V
    Urol Int; 2006; 77(3):255-63. PubMed ID: 17033215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombospondin-1, vascular endothelial growth factor expression and their relationship with p53 status in prostate cancer and benign prostatic hyperplasia.
    Kwak C; Jin RJ; Lee C; Park MS; Lee SE
    BJU Int; 2002 Feb; 89(3):303-9. PubMed ID: 11856116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of pioglitazone on expression of hypoxia-inducible factor 1α and vascular endothelial growth factor in ischemic hindlimb of diabetic rats.
    Zhang M; Gao X; Bai SJ; Ye XM; Zhang J
    Eur Rev Med Pharmacol Sci; 2014; 18(9):1307-14. PubMed ID: 24867508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of dutasteride on the expression of hypoxia-inducible factor-1alpha, vascular endothelial growth factor and microvessel density in rat and human prostate tissue.
    Ku JH; Shin JK; Cho MC; Myung JK; Moon KC; Paick JS
    Scand J Urol Nephrol; 2009; 43(6):445-53. PubMed ID: 19968580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative study of thulium laser resection of the prostate and bipolar transurethral plasmakinetic prostatectomy for treating benign prostatic hyperplasia.
    Peng B; Wang GC; Zheng JH; Xia SQ; Geng J; Che JP; Yan Y; Huang JH; Xu YF; Yang B
    BJU Int; 2013 Apr; 111(4):633-7. PubMed ID: 23107074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transforming growth factor beta 1 and androgen receptors in prostate neoplasia.
    Cardillo MR; Petrangeli E; Salvatori L; Ravenna L; Di Silverio F
    Anal Quant Cytol Histol; 2000 Oct; 22(5):403-10. PubMed ID: 11064817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Holmium:YAG transurethral incision versus laser photoselective vaporization for benign prostatic hyperplasia in a small prostate.
    Elshal AM; Elkoushy MA; Elmansy HM; Sampalis J; Elhilali MM
    J Urol; 2014 Jan; 191(1):148-54. PubMed ID: 23845460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased growth factor production in a human prostatic stromal cell culture model caused by hypoxia.
    Berger AP; Kofler K; Bektic J; Rogatsch H; Steiner H; Bartsch G; Klocker H
    Prostate; 2003 Sep; 57(1):57-65. PubMed ID: 12886524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
    Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
    J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidermal growth factor modulates the expression of vascular endothelial growth factor in the human prostate.
    Ravindranath N; Wion D; Brachet P; Djakiew D
    J Androl; 2001; 22(3):432-43. PubMed ID: 11330643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunolocalization of the keratinocyte growth factor in benign and neoplastic human prostate and its relation to androgen receptor.
    Planz B; Aretz HT; Wang Q; Tabatabaei S; Kirley SD; Lin CW; McDougal WS
    Prostate; 1999 Dec; 41(4):233-42. PubMed ID: 10544296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.